AstraZeneca Plc is licensing a drug from China’s CSPC Pharmaceutical Group Ltd that it hopes will treat high cholesterol, as the pharma company seeks to bolster its cardiovascular pipeline.
(Bloomberg) -- AstraZeneca Plc is licensing a drug from China’s CSPC Pharmaceutical Group Ltd that it hopes will treat high cholesterol, as the pharma company seeks to bolster ... the company’s ...
To prevent these problems, doctors often prescribe cholesterol-lowering drugs. Statins are the most commonly prescribed cholesterol-lowering medications, used by more than 200 million people ...
There are ways to achieve moderate lowering of cholesterol levels without using such drugs. If you are basically healthy, and a formal assessment of your cardiovascular risk places you in a low-risk ...